Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Alzheimers Dement. 2017 Mar 3;13(9):1024–1030. doi: 10.1016/j.jalz.2017.01.022

Table 1.

Descriptive Statistics

Amyloid Elevated (N = 27) Amyloid Non-Elevated (N = 70)
Age, years 73.1 (4.8) 71.2 (5.7)
Education, years 16.2 (3.0) 16.8 (2.4)
Female, N (%) 14 (51.9%) 45 (64.3%)
Caucasian, N (%) 27 (100%) 67 (95.7)
Hispanic, N (%) 0 (0%) 1 (1.4%)
Family History, N (%) 3 (11.1%) 11 (15.7%)
MMSE 29.2 (0.9) 29.1 (1.2)
STAI 33.9 (5.5) 33.8 (5.3)
BAI Pre-Scan 3.7 (3.1) 3.7 (4.0)
BAI Disclosure 4.3 (4.6) 3.7 (3.6)
BAI 6 Weeks 2.6 (2.9) 3.5 (4.1)
BAI 6 Months 2.6 (3.0) 3.6 (4.2)
CES-D Pre-Scan 3.7 (4.5) 3.4 (4.1)
CES-D Disclosure 4.0 (5.4) 4.0 (4.2)
CES-D 6 Weeks 2.5 (2.1) 3.9 (5.2)
CES-D 6 Months 3.7 (4.3) 4.2 (4.4)

All values are means (SD) unless otherwise noted. Family history reported by participant includes any cognitive or behavioral change in biological parents, full siblings and biological children. No differences were observed across groups (all p values > 0.05). MMSE = Mini-mental State Exam; BAI = Beck Anxiety Inventory; CES-D = Centers of Epidemiologic Studies Depression Scale